International Immunology, Vol. 15, No. 3, pp. 383-392,
March 2003
© 2003 Japanese Society for Immunology
Haploinsufficiency of B cell linker protein enhances B cell signaling defects in mice expressing a limiting dosage of Bruton’s tyrosine kinase
1 Simmons Arthritis Research Center, Department of Internal Medicine and Center for Immunology, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA 2 Division of Rheumatology, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA 3 Howard Hughes Medical Institute, and Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095, USA
Correspondence to: A. B. Satterthwaite; E-mail: anne.satterthwaite{at}utsouthwestern.edu
Transmitting editor: T. Tedder
Current models of lymphocyte activation suggest that formation of a signaling complex, or ‘signalosome’, composed of Syk, Bruton’s tyrosine kinase (Btk), phospholipase 
2 and the adaptor protein B cell linker protein (BLNK) is critical for transmission of signals from the BCR. However, impaired B cell development in mice lacking each individual signalosome component has made it difficult to study the functional consequences of the formation of this complex in mature B cells. Sensitized genetic systems, commonly used in Drosophila, define signaling pathways by combining partial loss of function mutations in the components of interest. This allows genetic interactions to be observed in the absence of pleiotropic or lethal effects of complete deficiency of either gene. We used this approach to demonstrate that Btk and BLNK are limiting components of a common signaling pathway that mediates the mitogenic response of mature B cells to antigen. B cells from transgenic mice expressing a limiting dosage of Btk (Btklo) have normal numbers of mature B cells that have reduced, but measurable, responses to BCR cross-linking. Haploinsufficiency of BLNK did not affect the development of Btklo B cells. However, it exacerbated their defects in BCR-induced Ca2+ flux, I
B degradation, and up-regulation of cyclin D2, bcl-xL and A1 leading to dramatic impairment of B cell mitogenic responses. In contrast, no effect of reduced Btk and BLNK dosage was observed on extracellular signal-regulated kinase activation. These results suggest that the signals regulating the maintenance and activation of mature B cells are differentially sensitive to the strength of the signal emanating from the signalosome.
Keywords: B lymphocyte, BCR, immunodeficiency diseases, knockout, signal transduction, transgenic
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Fehrenbach, E. Lessmann, C. N. Zorn, M. Kuhny, G. Grochowy, G. Krystal, M. Leitges, and M. Huber Steel Factor Enhances Supraoptimal Antigen-Induced IL-6 Production from Mast Cells via Activation of Protein Kinase C-{beta} J. Immunol., June 15, 2009; 182(12): 7897 - 7905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Martin, L. Lu, M. Cascalho, and G. E. Wu Maintenance of Surrogate Light Chain Expression Induces Developmental Delay in Early B Cell Compartment J. Immunol., October 15, 2007; 179(8): 4996 - 5005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Hinman, J. N. Bushanam, W. A. Nichols, and A. B. Satterthwaite B Cell Receptor Signaling Down-Regulates Forkhead Box Transcription Factor Class O 1 mRNA Expression via Phosphatidylinositol 3-Kinase and Bruton's Tyrosine Kinase J. Immunol., January 15, 2007; 178(2): 740 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Xu, J. Huo, W.-K. Chew, M. Hikida, T. Kurosaki, and K.-P. Lam Phospholipase C{gamma}2 Dosage Is Critical for B Cell Development in the Absence of Adaptor Protein BLNK. J. Immunol., April 15, 2006; 176(8): 4690 - 4698. [Abstract] [Full Text] [PDF]
|
|